GENEVA, Oct. 1 -- TG THERAPEUTICS, INC. (2 Gansevoort Street9th FloorNew York, NY 10014) filed a patent application (PCT/US2025/020453) for "SUBCUTANEOUS FORMULATIONS OF ANTI-CD20 ANTIBODY" on Mar 18, 2025. With publication no. WO/2025/199155, the details related to the patent application was published on Sep 25, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): MISKIN, Hari, P. (2 Gansevoort Street9th FloorNew York, NY 10014), AVGERINOS, George, Costas (2 Gansevoort StreetNew York, NY 10014)
Abstract: Provided herein are subcutaneous formulations of anti-CD20 antibody proteins, and methods o...